In vitro peripheral blood mononuclear cell proliferation, cytokine secretion and oxidative stress modulation by pyrido[2,3-d] pyrimidines
- 4 Downloads
The aim of this work was to study the in vitro effects of new pyrido[2,3-d] pyrimidines, especially 4-(N-phenylethylamino)-5,7-diphenylpyrido[2,3-d] pyrimidine (3a) and 4-(N-benzylamino)-5-(4-chlorophenyl)-7-(3-methoxyphenyl) pyrido[2,3-d]-pyrimidine (3b), on the proliferative responses of human peripheral blood mononuclear cells, cytokine secretion, ATP levels and intracellular redox status. Peripheral blood mononuclear cells were isolated using differential centrifugation on a density gradient of Histopaque. These cells were cultured with the mitogen concanavalin A (Con A) and with different concentrations of the compounds 3a and 3b (1–100 µM). Proliferation (MTT assay), IL-2, INFγ and IL-4 (Elisa kits), ATP levels, cytotoxic effect (micronucleus test) and oxidative markers (intracellular glutathione, superoxide dismutase, catalase, hydroperoxide and carbonyl protein contents) were investigated after 48-h incubation. Our results showed that 3a was immunostimulant at low concentrations but immunosuppressive at high concentrations (50, 100 µM) with a modulation of cytokine secretion. 3b was immunostimulant in a dose-dependent manner. 3a induced an increase in intracellular ATP levels at 1–25 µM but a decrease at 50–100 µM. In the presence of 3b, cell ATP contents increased with 3b concentrations. Peripheral blood mononuclear cell redox markers were consistent with the presence of an oxidative stress induced by high concentrations of 3a and 3b, with a significant increase in the micronucleus frequency in lymphocytes, suggesting cytotoxic effects. However, 3a at low concentrations (1–25 µM) tended to activate antioxidant defense in cells. In conclusion, 3a and 3b modulate cell-mediated immunity, cell energy and redox status at low concentrations.
KeywordsCell ATP Cytokines Peripheral blood mononuclear cells Proliferation Pyrido[2,3-d] pyrimidines Oxidative stress
This work was financial supported by the ‘Ministère de la Recherche et des Nouvelles Technologies’. The authors thank DGRST and the University of Tlemcen for funding this work.
The authors have no conflicting financial interests.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest regarding the publication of this paper.
- Attri P, Bhatia R, Gaur J, Arora B, Gupta A, Kumar N, Choi EH (2014) Triethyl ammonium acetate ionic liquid assisted one-pot synthesis of dihydropyrimidinones and evaluation of their antioxidant and antibacterial activities. Arab J Chem 10:1016Google Scholar
- Baba Hamed Y, Merzouk H, Harek Y, Medjdoub A, CherrakS Larabi L, Narce M (2014) In vitro effects of nickel (II) and copper (II) complexes with 2,5-bis(2-pyridyl)-1,3,4-thiadiazole on T lymphocyte proliferation and intracellular redox status. Med Chem Res 10:1115–1119Google Scholar
- Barile FA (1997) Continuous cell lines as a model for drug toxicity assessment. In: In vitro methods pharmaceutical research, pp 33–54Google Scholar
- Dwyer JM, Johnson C (1981) The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol 46:237–249Google Scholar
- Naoyuki K, Hyder J, Raoul H, Kuilenburg A (2013) Purine and pyrimidine metabolism. Emery and Rimoin’s principles and practice of medical genetics. Academic Press, San DiegoGoogle Scholar
- Reck F, Alm R, Brassil P, Newman J, DeJonge B, Eyermann CJ, Breault G, Breen J, Comita- Prevoir J, Cronin M, Davis H, Ehmann D, Galullo V, Geng B, Grebe T, Morningstar M, Walker P, Hayter B, Fisher S (2011) Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity. J Med Chem 54(22):7834–7847CrossRefGoogle Scholar
- Schmidtke JR, Hatfield S (1976) Activation of purified human T cells by mitogens: diminished mitogen-induced deoxyribonucleic acid synthesis in human T cells compared with autologous peripheral blood lymphocytes. Infect Immun 13:1061–1068Google Scholar
- Shamroukh AH, Rashad AE, Abdelmegeid FME (2016) The chemistry of pyrido[2,3-d]pyrimidines and their applications. J Chem Pharm Res 8(3):734–772Google Scholar
- Shaoyong KE, Liqiao SHI, Zhigang Z, Ziwen Y (2011) Steroidal[17,16-d]pyrimidines derived from dehydroepiandrosterone: a convenient synthesis, antiproliferation activity, structure-activity relationships, and role of heterocyclic moiety. Sci Rep 7:44439Google Scholar
- Singh G, Singh G, Yadav AK, Mishraa K (2002) Synthesis and antimicrobial evaluation of some new pyrido[2,3-d]pyrimidines and their ribofuranosides. Indian J Chem 41:430–432Google Scholar
- Wahab S, Hussain A (2013) Cytokines as targets for immunomodulation. Int J Pharm Pharm Sci 5:60–64Google Scholar